↓ Skip to main content

News Flash: Old Mother Hubbard Reports the Cupboard is Bare… Time for the FDA to Let Droperidol Out of the (Black) Box

Overview of attention for article published in Annals of Pharmacotherapy, September 2012
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
16 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
News Flash: Old Mother Hubbard Reports the Cupboard is Bare… Time for the FDA to Let Droperidol Out of the (Black) Box
Published in
Annals of Pharmacotherapy, September 2012
DOI 10.1345/aph.1r156
Pubmed ID
Authors
Abstract

A quick way for a clinical pharmacist to eliminate himself or herself from "employee of the month" consideration is to mention the term medication shortage. Even with training geared toward maximizing resources, the cumulative disappearance of a plethora of medications for the treatment of nausea, vomiting, and/or primary headaches is almost too much for emergency medicine physicians to manage. With prochlorperazine, metoclopramide, promethazine, and ondansetron in increasingly short supply, it is time for the Food and Drug Administration to revisit droperidol's black box warning driven by QTc interval prolongation, given its questionable validity, and restore droperidol's place in the armamentarium of emergency medicine physicians.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
United States 1 6%
Unknown 15 94%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Doctoral Student 2 13%
Student > Bachelor 2 13%
Researcher 2 13%
Professor > Associate Professor 2 13%
Other 1 6%
Other 3 19%
Unknown 4 25%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 7 44%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Business, Management and Accounting 1 6%
Immunology and Microbiology 1 6%
Psychology 1 6%
Other 0 0%
Unknown 5 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 July 2012.
All research outputs
#18,310,549
of 22,671,366 outputs
Outputs from Annals of Pharmacotherapy
#2,801
of 3,210 outputs
Outputs of similar age
#130,463
of 170,319 outputs
Outputs of similar age from Annals of Pharmacotherapy
#25
of 35 outputs
Altmetric has tracked 22,671,366 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,210 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one is in the 4th percentile – i.e., 4% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 170,319 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.